Assessment of the deamination of aminoacetone, an endogenous substrate for semicarbazide-sensitive amine oxidase

Analytical Biochemistry

Volumn 270, Issue 1, 1999, Pages 97-102

  Deng, Yulin ^a   Yu, Peter H ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Aminoacetone; Deamination; Diabetic complications; Methylglyoxal; SSAO

Indexed keywords

AMINO ACIDS;

AMINOACETONE; DEAMINATION; DIABETIC COMPLICATIONS; METHYLGLYOXAL; SSAO;

AMINES;

1,2 PHENYLENEDIAMINE; 2,4 DINITROPHENYLHYDRAZINE; ALKANE DERIVATIVE; AMINE OXIDASE (COPPER CONTAINING); AMINOACETONE; CLORGYLINE; GLYCINE; METHYLGLYOXAL; MOFEGILINE; SELEGILINE; SEMICARBAZIDE; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; DEAMINATION; DERIVATIZATION; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0033562836     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.1999.4058     Document Type: Article

References (33)

1. Lewinsohn R. Brez. J. Med. Biol. Res. 17:1984;223-256.
2. Lyles G. A., Singh I. J. Pharm. Pharmacol. 37:1985;637-643.
3. Yu P. H., Zuo D. M., Davis B. A. Biochem. Pharmacol. 47:1994;1055-1059.
4. Smith D. J., Salmi M., Bono P., Hellman J., Leu T., Jalkanen S. J. Exp. Med. 188:1998;17-27.
5. Zhang X., McIntire W. S. Gene. 179:1996;279-286.
6. Holt A., Alton G., Scaman C. H., Loppnow G. R., Szpaconko A., Svendsen I., Palcic M. M. Biochemistry. 37:1998;4946-4957.
7. Yu P. H. J. Pharm. Pharmacol. 42:1990;882-884.
8. Precious E., Gunn C. E., Lyles G. A. Biochem. Pharmacol. 37:1988;707-713.
9. Lyles G. A., Chalmers J. Biochem. Pharmacol. 43:1992;1409-1414.
10. Callingham B. A., Croshie A. E., Rous B. A. Prog. Brain Res. 106:1995;305-321.
11. McLellan A. C., Phillips S. A., Thornalley P. J. Anal. Biochem. 206:1992;17-23.
12. Nilsson S. E., Tryding N., Tufvesson G. Acta Med. Scand. 184:1968;105-108.
13. Tryding N., Nilsson S. E., Tufvesson G., Berg R., Carlstrom S., Elmfors B., Nilsson J. E. Scand. J. Clin. Lab. Invest. 23:1969;79-84.
14. Boomsma F. H. M., van den Meiracker A. H., Veld A. J. M., Schalekamp M. A. D. H. Clin. Sci. 88:1995;675-679.
15. Hayes B. E., Clarke D. E. Res. Commun. Chem. Pathol. Pharmacol. 69:1990;71-83.
16. Boomsma F., Van Veldhuisen D. J., De Kam P. J., In't Veld A. J. M., Mosterd A., Lie K. I., Schalekamp M. A. D. H. Cardiovasc. Res. 33:1997;387-391.
17. Yu P. H. J. Neural Transmembr. 52:1997;207-222.
18. Yu P. H., Zuo D. M. Diabetes. 42:1993;594-603.
19. Elliott W. H. Biochem. J. 74:1960;478-485.
20. Bird M. I., Nunn P. B., Lord L. Biochem. Biophys. Acta. 802:1984;229-236.
21. Urata G., Granick S. J. Biol. Chem. 238:1963;811-820.
22. Tressel T., Thompson R., Zieske L. R., Menendez M. I. T. S., David L. J. Biol. Chem. 261:1986;16428-16437.
23. Elliott W. H. Nature. 185:1960;467-468.
24. Lyles G. A., Marshall C. M. S., McDonald I. A., Bey P., Palfreyman M. G. Biochem. Pharmacol. 36:1987;2847-2853.
25. Ray M., Ray S. J. Biol. Chem. 262:1987;5974-5977.
26. Guilbault G. G., Brignac P. J., Juneau M. Anal. Biochem. 40:1968;1256-1263.
27. Croskie A. E., Callingham B. A. J. Neural Transmembr. 41:1994;427-432.
28. Cooper R. A. Methods Enzymol. 41:1975;502-508.
29. Ray S., Ray M. J. Biol. Chem. 258:1983;3461-3462.
30. Ohmori S., Mori M., Shiraha K., Kawase M. Enzymology and Molecular Biology of Carbonyl Metabolism. 1989;Liss, New York. p. 397-412.
31. Yu P. H. Boulton A. A., Baker G., Yu P. H. Neuromethods: Neurotransmitter Enzymes. 1986;235-272 Humana, Clifton.
32. Bradford M. M. Anal. Biochem. 72:1976;248-254.
33. Ahmed M. U., Frye E. B., Degenhardt T. P., Thorpe S. R., Baynes J. W. Biochem. J. 324:1997;565-570.